Keyphrases
Early Psychosis
100%
Prolactin
70%
Psychotic Disorders
66%
Hyperprolactinemia
45%
Cognitive Functioning
43%
First-episode Psychosis
41%
Free Thyroxine
40%
Pharmacological Treatment
40%
Schizophrenia
39%
Treatment Strategy
37%
Sex Differences
37%
Meta-analysis
37%
Attention Deficit Disorder
37%
Hyperactivity Disorder
37%
Randomized Clinical Trial
35%
Recent-onset Psychosis
33%
Cognitive Performance
33%
HPA Axis
32%
Thyroid Hormones
29%
Psychosis
27%
Aripiprazole
26%
Prolactin Levels
25%
Childhood Maltreatment
25%
Antipsychotics
25%
At-risk Mental State
23%
Clinical High Risk for Psychosis (CHR-P)
22%
Cognitive Task
21%
Processing Speed
21%
Systematic Meta-analysis
21%
Executive Function
20%
COVID-19 Pandemic
18%
Suicide
18%
Clinical Correlation
18%
Cross-sectional Comparison
18%
Gene-environment Interaction
18%
Val66Met Polymorphism
18%
Psychosocial Stress
18%
Brain-derived Neurotrophic Factor Val66Met
18%
Stress-related Biomarkers
18%
Psychiatric Profile
18%
Hair Cortisol
18%
1-year Follow-up
18%
Psychotic Symptoms
18%
Cognitive Remediation Therapy
18%
Clinical Variables
18%
Healthy Individuals
18%
Disorder Effects
18%
Dietary Intake
18%
Childhood Trauma
18%
Cognitive Bias
18%
Neuroscience
Early Psychosis
97%
Psychosis
69%
Prolactin
63%
Cortisol
59%
Hypothalamic-Pituitary-Adrenal Axis
44%
Thyroxine
40%
Attention Deficit Hyperactivity Disorder
37%
Hyperactivity
37%
Thyroid Hormone
30%
Executive Function
26%
Pediatric Trauma
23%
Aripiprazole
21%
Cognitive Change
18%
Brain-Derived Neurotrophic Factor
18%
Vigilance
18%
Generalized Linear Model
18%
Depression
18%
Conduct Disorder
18%
Anxiety Disorder
18%
Cognitive Bias
18%
Glycosylated Hemoglobin
18%
Antipsychotic
18%
Meta-Analysis
18%
Major Affective Disorder
18%
Cognitive Function
17%
Cortisol Awakening Response
17%
Cognitive Disorders
16%
Thyroid-Stimulating Hormone
15%
Visual Memory
14%
Metabolic Pathway
14%
Blood Plasma
13%
Depression
12%
Positive Syndrome
11%
C Peptide
9%
Hemoglobin A1c
9%
Body Mass Index
9%
Working Memory
8%
Bipolar Disorder
8%
Cognitive Process
7%
Placebo
7%
Negative Syndrome
6%
Verbal Memory
6%
Thyroid
6%
Major Depressive Disorder
5%
Cabergoline
5%
Psychology
Adolescence
67%
Psychotic Disorder
58%
Cortisol
56%
Cognitive Functioning
56%
Attention Deficit
37%
Sex Differences
37%
Executive Function
37%
Cognitive Performance
36%
Childhood Maltreatment
25%
Schizophrenia
25%
Multiple Linear Regression
21%
Vigilance
20%
Cognitive Bias
18%
Mixed Model
18%
Perceived Stress
18%
Pharmacological Treatment
18%
Cognitive Change
18%
Gene-Environment Interaction
18%
Meta-Analysis
18%
Sustained Attention
18%
Processing Speed
18%
Cognitive Function
17%
Working Memory
15%
Depression
13%
Body Mass Index
12%
Salivary Cortisol
12%
Cognitive Assessment
11%
Emotional Neglect
9%
Cognitive Deficit
9%
Mental State
9%
Neglect
9%
Systematic Review
7%
Univariate Statistics
6%
Insulin Resistance
6%
Benzodiazepine
6%
Factor Analysis
6%
Cognitive Process
6%
Sex Education
6%
Cognitive Impairment
6%
Dependent Variable
6%
Multivariate Analysis
6%
Estradiol
6%
Progesterone
6%
Anxiety Disorder
5%
Depression
5%